Sandoz incorporates RFID technology on injectables

Sandoz, a division of Novartis specializing in production of generic pharmaceuticals and biosimilars, has partnered with Kit Check (a company offering artificial intelligence and radio-frequency identification medication management technology).

Starting this month, two RFID-tagged injectable Sandoz products will be available in US hospitals.

RFID allows detailed and interoperable item-level data that can be scanned and updated without line of sight means.